|
|
|
|
|
03.12.25 - 21:45
|
Vanco and ACS Technologies Unite to Deliver More Connected Services and Solutions for Churches (Business Wire)
|
|
|
Trusted church management provider ACS Technologies and secure payments leader Vanco come together to serve more churches with a connected, seamless experience.
MINNEAPOLIS--(BUSINESS WIRE)--Vanco, a leader in secure digital payments and online giving for faith communities, schools, and nonprofits, and ACS Technologies (ACST), the category pioneer and market leader in church management software and services, today announced they will come together as one organization to help ministries spend less time on systems and more time with people.
Together, the companies will bring trusted church management and secure payments under one accountable team, so churches get faster answers, fewer handoffs and clear ownership when help is needed.
Vanco and ACST have worked as partners for over a decade, and their combined reach now serves more than 40,000 churches and ministries. Vanco's faith organization will operate under the ACS Technologies name, and its trusted payments capabilities will be woven into ACST's lea...
|
|
|
01.12.25 - 12:06
|
Ronovo Surgical Announces Appointment of Non-Executive Directors to Accelerate Global Growth (Business Wire)
|
|
|
SHANGHAI--(BUSINESS WIRE)--#MIS--Ronovo Surgical, a global innovator in next-generation surgical robotics, announces today the appointment of Dr. Eduardo Parra-Davila and Jeroen M.M. van Heesewijk as Non-Executive Directors to its Board of Directors.
Dr. Parra-Davila is one of the world's leading general surgeons with over 25 years of experience and over 5,000 cases of robotic surgery. He currently serves as Chief of General Surgery and Director of Minimally Invasive Colorectal Surgery and Hernia/Abdominal Wall Reconstruction at Good Samaritan Medical Center in West Palm Beach (Florida). As a founding member of the Society of Robotic Surgery (SRS) and the Clinical Robotic Surgery Association (CRSA), Dr. Parra-Davila has trained thousands of surgeons globally in minimally invasive and robotic surgery. He is also a contributing member of American College of Surgeons (ACS), Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), American Hernia Society (AHS) and American Society of Colon and R...
|
|
|
|
|
|
|
|
|
14.11.25 - 17:42
|
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy (Benzinga)
|
|
|
Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026.
Latest Ratings for BMY
DateFirmActionFromTo Mar 2022Wells FargoMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnBuy Dec 2021Wells FargoInitiates Coverage OnEqual-Weight
View More Analyst Ratings for BMY
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
